Epratuzumab for patients with moderate to severe flaring SLE: Health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006

Vibeke Strand, Michelle Petri, Kenneth Kalunian, Caroline Gordon, Daniel J. Wallace, Kathryn Hobbs, Lexy Kelley, Brian Kilgallen, William A. Wegener, David M. Goldenberg

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Epratuzumab for patients with moderate to severe flaring SLE: Health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006'. Together they form a unique fingerprint.

Medicine & Life Sciences